Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Financial Statements - Additional Information (Details)

v3.20.2
Condensed Consolidating Financial Statements - Additional Information (Details)
Jan. 21, 2020
USD ($)
Debtinstrument
Iterum Therapeutics Bermuda Limited  
Condensed Financial Statements Captions [Line Items]  
Ownership percentage 100.00%
Subsidiary Guarantors  
Condensed Financial Statements Captions [Line Items]  
Ownership percentage 100.00%
Private Placement | 2025 Exchangeable Notes  
Condensed Financial Statements Captions [Line Items]  
Aggregate principal amount $ 51,600,000
Debt instrument price per unit 1,000
Private Placement | RLNs  
Condensed Financial Statements Captions [Line Items]  
Aggregate principal amount $ 100,000
Number of debt instruments within each notes | Debtinstrument 50